4 unknown. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 1 | Unknown 1 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis Belimumab, Rituximab, Prednisolone - ANCA Associated Vasculitis, Granulomatosis With Polyangiitis | Phase 2 | Unknown | Rachel Jones | 31 | 2019-02-01 | 2022-03-08 |
| CMV Modulation of the Immune System in ANCA-associated Vasculitis Valaciclovir - ANCA Associated Vasculitis, CMV Infection | Phase 2 | Unknown | Professor Lorraine Harper | 38 | 2013-07-01 | 2016-11-30 |
| Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides Methotrexate, Cyclophosphamide - Wegener's Granulomatosis, Churg-Strauss Syndrome | Phase 2 | Unknown | University of Parma | 2008-09-12 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Granulomatosis with Polyangiitis (2) · Arthritis, Rheumatoid (1) · Churg-Strauss Syndrome (1) · Cytomegalovirus Infections (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1) · Microscopic Polyangiitis (1) · Polyarteritis Nodosa (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1) · Undifferentiated Connective Tissue Diseases (1) · Vasculitis (1)
Autoimmune Diseases (4) · Cardiovascular Diseases (4) · Immune System Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Vascular Diseases (4) · Skin Diseases, Vascular (3) · Vasculitis (3) · Lung Diseases (2) · Lung Diseases, Interstitial (2) · Respiratory Tract Diseases (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arteritis (1) · Arthritis (1)
COVID-19 Vaccines (1) · Cyclophosphamide (1) · Methotrexate (1) · Prednisolone (1) · Prednisone (1) · Rituximab (1) · Valacyclovir (1) · belimumab (1)
Paul R Fortin (1) · Professor Lorraine Harper (1) · Rachel Jones (1) · University of Parma (1)
United Kingdom (2) · Canada (1) · Italy (1)
Carlo Buzio, MD (1) · Lorraine Harper, MRCP PhD (1) · Paul R Fortin, MD,MPH,FRCPC (1) · Rachel B Jones (1)
PMID 26312852, PMID 27450392, PMID 29016646, PMID 30102389, PMID 33164993, PMID 36906660